Precision medicine is a market catching fire. The growth is so rapid that analysts have projected spending in the field will approach $87 annually within six years. With more healthcare organizations investing in the technologies, expectations are growing for significant advances in improved treatment and early detection of disease. The HIMSS Precision Medicine Summit Read More …
Category: Uncategorized
Precision medicine improves treatment outcomes for some pancreatic cancer patients
UNIVERSITY OF PITTSBURGH SCHOOLS OF THE HEALTH SCIENCES PUBLIC RELEASE: 9-MAY-2017 University of Pittsburgh and UPMC researchers are paving the way for genome-targeted treatments in pancreatic cancer, an especially deadly form of cancer with few existing therapeutic options, according to a pair of recent studies. The first study used genomic profiling to identify targeted therapies that Read More …
US can’t afford to be left behind in precision medicine ‘gold rush’
BY JOHN SOTOS, M.D., STEVE ROSENBERG, AND MORTEN SOGAARD, PH.D., OPINION CONTRIBUTORS – 05/05/17 08:00 AM EDT Precision medicine is the next step in the medical profession’s 2,500-year quest to individualize medical treatments — and one of the most significant. Often called the next “space race” because of the immense technological advances required to make Read More …
In the Pursuit of Precision Medicine and Value-Based Care: Are They Dual, Yet Synergistic Goals?
In the Pursuit of Precision Medicine and Value-Based Care: Are They Dual, Yet Synergistic Goals? April 26, 2017 by Heather Landi Within the healthcare industry, precision medicine often is approached as a research endeavor, while value-based care transformation is framed as a business or operational initiative. However, one bioinformatics thought-leader asserts that precision medicine and Read More …
Precision Medicine Startup AltheaDx Lands $27M
Precision Medicine Startup AltheaDx Lands $27M to Expand Personalized Therapeutic Decisions Internationally by Fred Pennic 04/26/2017 http://hitconsultant.net/2017/04/26/altheadx-precision-medicine-series-b/
New Genetics Test Can Help Avoid Adverse Drug Reactions
New Genetics Test Can Help Avoid Adverse Drug Reactions by JAMES E. CASTO For the State Journal Apr 15, 2017 Fruth Pharmacy is now offering Rxight, a new testing program that uses a person’s genetic profile to help identify the medications that will work best for him or her, while avoiding possible adverse drug reactions Rxight, Read More …
FROM FDA: Table of Pharmacogenomic Biomarkers in Drug Labeling
Table of Pharmacogenomic Biomarkers in Drug Labeling Pharmacogenomics can play an important role in identifying responders and non-responders to medications, avoiding adverse events, and optimizing drug dose. Drug labeling may contain information on genomic biomarkers and can describe: Drug exposure and clinical response variability Risk for adverse events Genotype-specific dosing Mechanisms of drug action Polymorphic Read More …
GEMM – Genetically Enhanced Medication Monitoring
Opioid over/misuse is an enormous problem that practitioners and payers are working hard to address. To that end, Insight Diagnostics has just introduced a new, low cost, lab test that significantly improves the diagnostic capabilities of physicians treating patients who are being prescribed opioids. Insight has combined two widely used and often expensive lab tests Read More …
GEMM – Genetically Enhanced Medication Monitoring
Opioid over/misuse is an enormous problem that practitioners and payers are working hard to address. To that end, Insight Diagnostics has just introduced a new, low cost, lab test that significantly improves the diagnostic capabilities of physicians treating patients who are being prescribed opioids. Insight has combined two widely used and often expensive lab tests Read More …
GEMM – Genetically Enhanced Medication Monitoring
Opioid over/misuse is an enormous problem that practitioners and payers are working hard to address. To that end, Insight Diagnostics has just introduced a new, low cost, lab test that significantly improves the diagnostic capabilities of physicians treating patients who are being prescribed opioids. Insight has combined two widely used and often expensive lab tests Read More …